HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: The benefit of corticosteroids
- 1 August 1999
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 181 (2), 304-309
- https://doi.org/10.1016/s0002-9378(99)70552-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndromeAmerican Journal of Obstetrics and Gynecology, 1997
- The HELLP syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1997
- Management of severe preeclampsiaCurrent Opinion in Obstetrics and Gynecology, 1996
- Postpartum corticosteroids: Accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)American Journal of Obstetrics and Gynecology, 1994
- Antepartum corticosteroids: Disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP)American Journal of Obstetrics and Gynecology, 1994
- Corticosteroids for Enhanced Fetal Lung Maturation in Patients with HELLP Syndrome: Impact on NeonatesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1993
- Corticosteroids for the Enhancement of Fetal Lung Maturity: Impact on the Gravida with Preeclampsia and the HELLP SyndromeAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1993
- The natural history of HELLP syndrome: Patterns of disease progression and regressionAmerican Journal of Obstetrics and Gynecology, 1991
- Clinical Significance, Prevalence, and Natural History of Thrombocytopenia in Pregnancy-Induced HypertensionAmerican Journal of Perinatology, 1989
- Thrombocytopenia in preeclampsia: Associated abnormalities and management principlesAmerican Journal of Obstetrics and Gynecology, 1984